264 related articles for article (PubMed ID: 4282801)
21. Fibrinogen and fibrin formation and its role in fibrinolysis.
Blombäck B
Biotechnology; 1991; 19():225-79. PubMed ID: 1723911
[No Abstract] [Full Text] [Related]
22. The fibrinolytic system and haemostasis.
Chesterman CN
Thromb Diath Haemorrh; 1975 Nov; 34(2):368-77. PubMed ID: 53891
[TBL] [Abstract][Full Text] [Related]
23. [Factor XIII, its physiological significance (a review of the literature)].
Baluda VP; Zhukova NA
Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):34-40. PubMed ID: 4271843
[No Abstract] [Full Text] [Related]
24. Experimental models of defibrination states.
Lipiński B
Pol Med J; 1971; 10(3):619-26. PubMed ID: 4256509
[No Abstract] [Full Text] [Related]
25. [Structure and function of fibrinogen].
Iwanaga S
Tanpakushitsu Kakusan Koso; 1969 Mar; 14(3):175-95. PubMed ID: 4240151
[No Abstract] [Full Text] [Related]
26. [Fibrinogen and its break-down products].
Gormsen J; Feddersen C
Ugeskr Laeger; 1973 Aug; 135(32):1678-82. PubMed ID: 4272617
[No Abstract] [Full Text] [Related]
27. [Participation of sialic acid residue in the fibrinogen-fibrin conversion by thrombin].
Akihama S; Matsuda Y; Fukase T; Yamanaka A; Okude M
Yakugaku Zasshi; 1995 Jul; 115(7):537-42. PubMed ID: 7562401
[TBL] [Abstract][Full Text] [Related]
28. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.
Shenkman B; Livnat T; Lubetsky A; Tamarin I; Budnik I; Einav Y; Martinowitz U
Blood Coagul Fibrinolysis; 2012 Jul; 23(5):370-8. PubMed ID: 22498982
[TBL] [Abstract][Full Text] [Related]
29. On the structure of functional sites in fibrinogen.
Henschen A
Thromb Res; 1983; Suppl 5():27-39. PubMed ID: 6225216
[TBL] [Abstract][Full Text] [Related]
30. Molecular basis for measurement of circulating fibrinogen derivatives.
Wilner GD
Prog Hemost Thromb; 1978; 4():211-48. PubMed ID: 152445
[TBL] [Abstract][Full Text] [Related]
31. Differential degradation by plasmin of fragment E derived from fibrin and fibrinogen.
Wallin R; Belew M; Gerdin B; Saldeen T
Thromb Res; 1980 Aug; 19(3):441-5. PubMed ID: 6449096
[No Abstract] [Full Text] [Related]
32. Fibrinogen and fibrin: biochemistry and pathophysiology.
Budzynski AZ
Crit Rev Oncol Hematol; 1986; 6(2):97-146. PubMed ID: 2878736
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the cross-linking patterns of lamprey fibrinogen and fibrin by the action of the intrinsic lamprey factor XIII and human factor XIII during the process of blood coagulation.
Murtaugh PA
Thromb Haemost; 1977 Aug; 38(2):429-37. PubMed ID: 579486
[TBL] [Abstract][Full Text] [Related]
34. Role of plasmin in the degradation of the stroma-derived fibrin in human ovarian carcinoma.
Wilhelm O; Hafter R; Henschen A; Schmitt M; Graeff H
Blood; 1990 Apr; 75(8):1673-8. PubMed ID: 2139349
[TBL] [Abstract][Full Text] [Related]
35. Degradation of non cross-linked and cross-linked fibrin clots by plasmin, trypsin, chymotrypsin and Brinase.
Gormsen J; Feddersen C
Thromb Res; 1974 Aug; 5(2):125-39. PubMed ID: 4278050
[No Abstract] [Full Text] [Related]
36. A serum-induced defect in fibrin formation.
Deykin D; Silversmith P; Ashford T
J Lab Clin Med; 1970 Nov; 76(5):761-74. PubMed ID: 4249037
[No Abstract] [Full Text] [Related]
37. Fibrinogen clottability and fibrin formation.
Alexander B
Thromb Diath Haemorrh Suppl; 1966; 20():191-200. PubMed ID: 4226518
[No Abstract] [Full Text] [Related]
38. The Role of Fibrinogen and Factor XIII in Hemostasis, and the Identification and Treatment of Associated Disorders.
Lisman T; de Moerloose P
Semin Thromb Hemost; 2016 Jun; 42(4):331-2. PubMed ID: 27232229
[No Abstract] [Full Text] [Related]
39. [Functional state of the anti-coagulation system of animals injected intravenously with fibrin-stabilizing factor].
Kudriashov BA; Rustamova BA; Molchanova LV; Ul'ianov AM
Vopr Med Khim; 1971; 17(5):524-9. PubMed ID: 5123470
[No Abstract] [Full Text] [Related]
40. Degradation of fibrinogen by plasmin: biological effects of the non-dialysable fibrinogen derivatives.
Triantaphyllopoulos DC; Chandra S
Thromb Diath Haemorrh Suppl; 1973; 56():113-26. PubMed ID: 4281938
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
